MC2 Partners with EPI for Commercialization of Wynzora – Practical Dermatology

MC2 Therapeutics has entered a Collaboration Agreement with EPI Health, LLC on the commercialization of Wynzora Cream (calcipotriene and betamethasone

Read the full article here

Related Articles